Menu Philippe 4

What Happened

• Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA (SOPH), sold a total of 4,731 shares in two open‑market transactions to satisfy tax withholding from recent RSU vesting. The filings report 2,800 shares sold on 2026-04-08 at a weighted average price of $4.84 (≈ $13,544) and 1,931 shares sold on 2026-04-09 at a weighted average price of $4.74 (≈ $9,152). Aggregate proceeds were about $22,696. These were sales (not purchases) and were executed pursuant to a pre‑established Rule 10b5‑1 plan.

Key Details

• Transaction dates and reported weighted average prices:
  • 2026-04-08: 2,800 shares sold, weighted avg $4.84 (range $4.78–$4.94) — Footnote F2
  • 2026-04-09: 1,931 shares sold, weighted avg $4.74 (range $4.655–$4.86) — Footnote F3
• Total shares sold: 4,731; approximate total proceeds: $22,696.
• Purpose / notable footnote: Sales were made to satisfy tax withholding obligations tied to RSU vestings on April 2 and 3, 2026, and were effected under a pre‑established Rule 10b5‑1 trading plan (Footnote F1). The reporting person states the trades were not discretionary.
• Ownership after transaction: Not disclosed in the provided filing excerpt; see the full Form 4 for post‑transaction holdings.
• Filing timeliness: No late‑filing flag indicated in the provided data.

Context

• Sales to cover tax withholding after restricted stock unit vesting are common and typically routine; they do not necessarily signal the insider’s view on the company’s outlook. The 10b5‑1 plan detail indicates the trades were pre‑planned rather than ad hoc.